Identfication of Potent LXRβ-Selective Agonists without LXRα Activation by In Silico Approaches

Identfication of Potent LXRβ-Selective Agonists without LXRα Activation by In Silico Approaches

Activating Liver X receptors (LXRs) represents a promising therapeutic option for dyslipidemia. However, activating LXRα may cause undesired lipogenic effects. Discovery of highly LXRβ-selective agonists without LXRα activation were indispensable for dyslipidemia. In thi...

Full description

Bibliographic Details
Main Authors: Meimei Chen, Fafu Yang, Jie Kang, Huijuan Gan, Xuemei Yang, Xinmei Lai, Yuxing Gao
Format: Article
Language:English
Published: MDPI AG 2018-06-01
Series:Molecules
Subjects:
LXRβ-selective agonists
QSAR modeling
molecular docking
Kohonen
Online Access:http://www.mdpi.com/1420-3049/23/6/1349

Internet

http://www.mdpi.com/1420-3049/23/6/1349

Similar Items